Cite
HARVARD Citation
Rosenkranz, S. et al. (n.d.). Changes in cMRI parameters following a switch to riociguat from phosphodiesterase type 5 inhibitors (PDE5i) in patients with pulmonary arterial hypertension: a REPLACE substudy. European heart journal. p. . [Online].